Meeting
2017 ASCO Annual Meeting
Phase III trial to evaluate the efficacy of neoadjuvant chemotherapy with S-1 plus oxaliplatin followed by D2 gastrectomy with adjuvant S-1 in locally advanced gastric cancer: Japan Clinical Oncology Group study JCOG1509 (NAGISA trial).
Authors
Masanori Tokunaga
Division of Gastric Surgery, Shizuoka Cancer Center, Nagaizumi, Japan
Masanori Tokunaga , Junki Mizusawa , Nozomu Machida , Takeo Fukagawa , Hitoshi Katai , Yasunori Nishida , Hiroshi Yabusaki , Seiji Ito , Takeshi Sano , Mitsuru Sasako , Narikazu Boku , Takaki Yoshikawa , Hiroshi Katayama , Haruhiko Fukuda , Masanori Terashima
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Esophageal or Gastric Cancer
Clinical Trial Registration Number
UMIN000024065
Citation
J Clin Oncol 35, 2017 (suppl; abstr TPS4134)
DOI
10.1200/JCO.2017.35.15_suppl.TPS4134
Abstract #
TPS4134
Poster Bd #
124b
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
A phase 2 study of durvalumab plus DOS (docetaxel, oxaliplatin, S-1) neoadjuvant chemotherapy followed by surgery and adjuvant durvalumab plus S-1 chemotherapy in patients with resectable locally advanced gastric cancer: An interim efficacy report.
First Author: Hyung-Don Kim
Poster
2020 Gastrointestinal Cancers Symposium
Multicenter phase II study of neoadjuvant chemotherapy with S-1 and oxaliplatin for locally advanced gastric cancer (Neo G-SOX PII).
First Author: Masato Kondo
Poster
2018 ASCO Annual Meeting
Oxaliplatin plus capecitabine (XELOX) in the perioperative treatment of locally advanced gastric adenocarcinoma in combination with D2 gastrectomy (NEO-CLASSIC).
First Author: Tianshu Liu
Poster
2017 Gastrointestinal Cancers Symposium
Phase I study of neoadjuvant chemotherapy with xeloda and oxaliplatin (G-XELOX) for locally advanced gastric cancer.
First Author: Hironaga Satake